mRNA: The State of Play in Oncology and Infectious Disease

This report covers the rise of mRNA and explores the modality’s potential in a range of applications within the infectious disease and oncology fields. Leveraging GlobalData’s proprietary data and insights, the report will analyze the current state of play in both infectious disease and oncology pipelines and discuss the opportunities and challenges in both. While exploring challenges, the report will focus on primary packaging considerations, which play a critical role in getting innovative new drugs to patients safely and effectively.